Description: Minerva Surgical Inc., a commercial-stage medical technology company, focuses on developing, manufacturing, and commercializing minimally invasive solutions to meet the uterine healthcare needs of women. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists across various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Home Page: minervasurgical.com
UTRS Technical Analysis
4255 Burton Drive
Santa Clara,
CA
95054
United States
Phone:
855 646 7874
Officers
| Name | Title |
|---|---|
| Mr. David M. Clapper | Pres, CEO & Director |
| Mr. Joel R. Jung MBA | Chief Financial Officer |
| Mr. Dominique J. Filloux | Chief Operating Officer |
| Mr. Thomas Pendlebury | VP of Sales & Marketing |
| Ms. Wendy Bowman | VP of HR |
| Ms. Joanne Long | VP of Corp. Controller |
| Dr. Evgueni V. Skalnyi M.D. | VP of Medical Affairs |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.2791 |
| Price-to-Sales TTM: | 0.1163 |
| IPO Date: | 2021-10-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 157 |